Robert B. Levy, Ph.D.
- Microbiology and Immunology
Dr. Levy’s lab studies the regulation of T lymphocyte responses to develop cell therapy strategies for improving hematopoietic stem cell transplantation HSCT. Using pre-clinical models of HSCT, he is developing translational approaches to suppress graft versus host disease (GVHD) while maintaining graft vs. tumor (GVL) responses. Promising combinatorial experimental regimens employ fusion proteins, antibodies, and reagents to manipulate Treg and T conventional cell numbers and function while inhibiting inflammatory pathways.